aTYR PHARMA INC 4
4 · aTYR PHARMA INC · Filed Feb 9, 2017
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blake John T
Vice President, Finance
Transactions
- Award
Restricted Stock Unit
2017-02-07+10,000→ 10,000 total→ Common Stock (10,000 underlying) - Award
Employee Stock Option (right to buy)
2017-02-07+55,000→ 55,000 totalExercise: $3.30Exp: 2027-03-07→ Common Stock (55,000 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 7, 2017, such that this option will be fully exercisable on February 7, 2021. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units (RSUs) are scheduled to vest in three equal annual installments beginning on February 7, 2018, such that this grant will be fully vest on February 7, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.